These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 31917124)

  • 21. Interplay between hypercholesterolaemia and inflammation in atherosclerosis: Translating experimental targets into clinical practice.
    Tuñón J; Bäck M; Badimón L; Bochaton-Piallat ML; Cariou B; Daemen MJ; Egido J; Evans PC; Francis SE; Ketelhuth DF; Lutgens E; Matter CM; Monaco C; Steffens S; Stroes E; Vindis C; Weber C; Hoefer IE;
    Eur J Prev Cardiol; 2018 Jun; 25(9):948-955. PubMed ID: 29759006
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting inflammation in cardiovascular diseases. still a neglected field?
    Gómez-Guerrero C; Mallavia B; Egido J
    Cardiovasc Ther; 2012 Aug; 30(4):e189-97. PubMed ID: 21884009
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inflammation, infection and atherosclerosis.
    Shah PK
    Trends Cardiovasc Med; 2019 Nov; 29(8):468-472. PubMed ID: 30733074
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A perspective on targeting inflammation and cytokine actions in atherosclerosis.
    Chan YH; Ramji DP
    Future Med Chem; 2020 Apr; 12(7):613-626. PubMed ID: 32175772
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting cytokines and immune checkpoints in atherosclerosis with monoclonal antibodies.
    Lutgens E; Joffre J; van Os B; Ait-Oufella H
    Atherosclerosis; 2021 Oct; 335():98-109. PubMed ID: 34593238
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nanoimmunotherapy to treat ischaemic heart disease.
    Duivenvoorden R; Senders ML; van Leent MMT; Pérez-Medina C; Nahrendorf M; Fayad ZA; Mulder WJM
    Nat Rev Cardiol; 2019 Jan; 16(1):21-32. PubMed ID: 30209355
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IL-17 and Th17 cells in atherosclerosis: subtle and contextual roles.
    Taleb S; Tedgui A; Mallat Z
    Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):258-64. PubMed ID: 25234818
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of inflammation in the pathogenesis of atherosclerosis and therapeutic interventions.
    Raggi P; Genest J; Giles JT; Rayner KJ; Dwivedi G; Beanlands RS; Gupta M
    Atherosclerosis; 2018 Sep; 276():98-108. PubMed ID: 30055326
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potential of anti-inflammatory agents for treatment of atherosclerosis.
    Chistiakov DA; Melnichenko AA; Grechko AV; Myasoedova VA; Orekhov AN
    Exp Mol Pathol; 2018 Apr; 104(2):114-124. PubMed ID: 29378168
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytokines as therapeutic targets to reduce cardiovascular risk in chronic inflammation.
    Miller AM; McInnes IB
    Curr Pharm Des; 2011; 17(1):1-8. PubMed ID: 21222645
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anticytokine Agents: Targeting Interleukin Signaling Pathways for the Treatment of Atherothrombosis.
    Ridker PM
    Circ Res; 2019 Feb; 124(3):437-450. PubMed ID: 30702995
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibody treatments of inflammatory arthritis.
    Brown MA
    Curr Med Chem; 2005; 12(25):2943-6. PubMed ID: 16378497
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The potential applications of mushrooms against some facets of atherosclerosis: A review.
    Amirullah NA; Zainal Abidin N; Abdullah N
    Food Res Int; 2018 Mar; 105():517-536. PubMed ID: 29433243
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inflammation and thrombosis: the clot thickens.
    Libby P; Simon DI
    Circulation; 2001 Apr; 103(13):1718-20. PubMed ID: 11282900
    [No Abstract]   [Full Text] [Related]  

  • 35. T cell-based therapies for atherosclerosis.
    Ketelhuth DF; Gisterå A; Johansson DK; Hansson GK
    Curr Pharm Des; 2013; 19(33):5850-8. PubMed ID: 23438952
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antithrombotic therapy in aortic diseases: A narrative review.
    Caron F; Anand SS
    Vasc Med; 2017 Feb; 22(1):57-65. PubMed ID: 28215108
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recent advances in therapeutic targeting of inflammation in atherosclerosis.
    Hedin U; Matic LP
    J Vasc Surg; 2019 Mar; 69(3):944-951. PubMed ID: 30591299
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polyphosphate as modulator of hemostasis, thrombosis, and inflammation.
    Morrissey JH; Smith SA
    J Thromb Haemost; 2015 Jun; 13 Suppl 1(0 1):S92-7. PubMed ID: 26149055
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Helping antibodies. Targeted antithrombotic and fibrinolytic therapy].
    Schwarz M; Hagemeyer CE; Peter K; Bode C
    Hamostaseologie; 2007 Dec; 27(5):360-2. PubMed ID: 18060247
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting Inflammation to Reduce Atherosclerotic Cardiovascular Risk in People With HIV Infection.
    Titanji B; Gavegnano C; Hsue P; Schinazi R; Marconi VC
    J Am Heart Assoc; 2020 Feb; 9(3):e014873. PubMed ID: 31973607
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.